Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jun 21, 2018 at 11:10 AM EDT

Why Everything Is Going Right for Heron Therapeutics

Heron Therapeutics shares made a massive gain on Thursday after the company announced a few key developments.

Chris Lange | Jun 21, 2018 at 9:15 AM EDT

Is Voyager Therapeutics Poised to Win Big With Parkinson’s Treatment?

For many drug developers, Parkinson’s disease is a tricky disease to treat. However, developing a treatment ultimately could yield a…

Chris Lange | Jun 20, 2018 at 12:40 PM EDT

The Search Is Over: JPMorgan, Amazon and Berkshire Hathaway Find CEO to Head Up Health Care Firm

Amazon.com, JPMorgan and Berkshire Hathaway are now making their combined health care plan a reality with the appointment of a…

Chris Lange | Jun 19, 2018 at 11:00 AM EDT

Why Sarepta Shares Are Skyrocketing

Sarepta Therapeutics shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy trial.

Chris Lange | Jun 19, 2018 at 10:30 AM EDT

Are FMI Shareholders Getting Enough in the Roche Acquisition?

Foundation Medicine shares saw a sizable jump early on Tuesday after the company announced that Roche would be acquiring all…

Paul Ausick | Jun 19, 2018 at 8:10 AM EDT

Fewer Americans Than Ever Are Smokers

Fewer Americans than ever are smoking, according to data released Tuesday by the Centers for Disease Control. Just under 14%…

Chris Lange | Jun 18, 2018 at 1:25 PM EDT

Forty Seven Announces Potential Pricing for IPO

Clinical-stage immuno-oncology company Forty Seven intends to price more than 6 million shares so that the entire offering is valued…

Chris Lange | Jun 18, 2018 at 10:35 AM EDT

Why PTC Therapeutics Shares Are Booming

PTC Therapeutics watched its shares make a massive gain early on Monday after the firm presented updated preliminary results from…

Chris Lange | Jun 18, 2018 at 9:40 AM EDT

FDA Lifts Clinical Hold on Solid Biosciences

Solid Biosciences watched its shares surge to kick off the week after the FDA lifted the clinical hold on its…

Lee Jackson | Jun 18, 2018 at 9:30 AM EDT

Valeant Pharmaceuticals Woes Continue as FDA Fails to Approve Plaque Psoriasis Lotion

Valeant Pharmaceuticals shares were down over 5% in premarket trading Monday after the FDA failed to approve the company's lotion…

Chris Lange | Jun 15, 2018 at 11:27 AM EDT

Neon Therapeutics Closes in on IPO

Neon Therapeutics filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering.…

Chris Lange | Jun 15, 2018 at 10:37 AM EDT

Affimed Sinks Despite Positive Interim Results

Affimed N.V. (NASDAQ: AFMD) shares dropped sharply early on Friday after the firm released new results from its early stage…

Lee Jackson | Jun 15, 2018 at 10:07 AM EDT

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a…

Chris Lange | Jun 14, 2018 at 1:36 PM EDT

Why Nightstar Is Thursday’s Top Biotech

Nightstar Therapeutics PLC (NASDAQ: NITE) shares saw a massive gain on Thursday after the firm announced a crucial decision from…

Chris Lange | Jun 14, 2018 at 10:28 AM EDT

Merck Wins Another FDA Approval For Keytruda

Merck & Co., Inc. (NYSE: MRK) shares took a small step back on Thursday after the company announced a key…

1 … 129 130 131 132 133 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Everything Is Going Right for Heron Therapeutics

Is Voyager Therapeutics Poised to Win Big With Parkinson’s Treatment?

The Search Is Over: JPMorgan, Amazon and Berkshire Hathaway Find CEO to Head Up Health Care Firm

Why Sarepta Shares Are Skyrocketing

Are FMI Shareholders Getting Enough in the Roche Acquisition?

Fewer Americans Than Ever Are Smokers

Forty Seven Announces Potential Pricing for IPO

Why PTC Therapeutics Shares Are Booming

FDA Lifts Clinical Hold on Solid Biosciences

Valeant Pharmaceuticals Woes Continue as FDA Fails to Approve Plaque Psoriasis Lotion

Neon Therapeutics Closes in on IPO

Affimed Sinks Despite Positive Interim Results

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Why Nightstar Is Thursday’s Top Biotech

Merck Wins Another FDA Approval For Keytruda

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

Why Everything Is Going Right for Heron Therapeutics

Is Voyager Therapeutics Poised to Win Big With Parkinson’s Treatment?

The Search Is Over: JPMorgan, Amazon and Berkshire Hathaway Find CEO to Head Up Health Care Firm

Why Sarepta Shares Are Skyrocketing

Are FMI Shareholders Getting Enough in the Roche Acquisition?

Fewer Americans Than Ever Are Smokers

Forty Seven Announces Potential Pricing for IPO

Why PTC Therapeutics Shares Are Booming

FDA Lifts Clinical Hold on Solid Biosciences

Valeant Pharmaceuticals Woes Continue as FDA Fails to Approve Plaque Psoriasis Lotion

Neon Therapeutics Closes in on IPO

Affimed Sinks Despite Positive Interim Results

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Why Nightstar Is Thursday’s Top Biotech

Merck Wins Another FDA Approval For Keytruda

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how